We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $688M
1-Year Est. Return 63.4%
This Fund
S&P 500
This Quarter Est. Return
+9.7%
1 Year Est. Return
+63.4%
3 Year Est. Return
+248.3%
5 Year Est. Return
+571.65%
10 Year Est. Return
+5,300.27%
AUM
$771M
AUM Growth
-$3.16M
Cap. Flow
-$568K
Cap. Flow %
-0.07%
Top 10 Hldgs %
29.71%
Holding
547
New
54
Increased
48
Reduced
36
Closed
76

Sector Composition

Rank Sector Weight
1 Financials 28.07%
2 Technology 22.78%
3 Healthcare 7.73%
4 Industrials 7.72%
5 Communication Services 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWI
326
DELISTED
SolarWinds Corporation Common Stock
SWI
$106K 0.01%
13,650
FLACU
327
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$104K 0.01%
10,200
BHC icon
328
Bausch Health
BHC
$2.32B
$103K 0.01%
15,000
+5,000
+50% +$34.7K
BLUA.U
329
DELISTED
BlueRiver Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary shares
BLUA.U
$100K 0.01%
10,100
EGIO
330
DELISTED
Edgio, Inc. Common Stock
EGIO
$96K 0.01%
863
DDD icon
331
3D Systems Corp
DDD
$603M
$94K 0.01%
11,800
PTON icon
332
Peloton Interactive
PTON
$2.38B
$90K 0.01%
+13,000
New +$132K
TBCH
333
Turtle Beach Corp
TBCH
$230M
$86K 0.01%
12,600
CCO icon
334
Clear Channel Outdoor Holdings
CCO
$1.23B
$77K 0.01%
56,000
AAOI icon
335
Applied Optoelectronics
AAOI
$11.7B
$75K 0.01%
27,500
+2,000
+8% +$4.51K
AUPH icon
336
Aurinia Pharmaceuticals
AUPH
$2.06B
$75K 0.01%
10,000
ARLO icon
337
Arlo Technologies
ARLO
$1.5B
$46K 0.01%
10,000
PRSTW
338
DELISTED
Presto Technologies, Inc. Warrant
PRSTW
$25K ﹤0.01%
301,100
PMVC.WS
339
DELISTED
PMV Consumer Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PMVC.WS
$22K ﹤0.01%
500,000
OPK icon
340
Opko Health
OPK
$1.04B
$19K ﹤0.01%
10,000
AXAC.RT
341
DELISTED
AXIOS Sustainable Growth Acquisition Corporation Rights to receive one-tenth (1/10) of one Class A ordinary share
AXAC.RT
$19K ﹤0.01%
173,500
PSPC.WS
342
DELISTED
Post Holdings Partnering Corporation Redeemable Warrants, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50
PSPC.WS
$16K ﹤0.01%
154,533
HMA.WS
343
DELISTED
Heartland Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
HMA.WS
$15K ﹤0.01%
129,969
ALSAR
344
DELISTED
Alpha Star Acquisition Corp Rights
ALSAR
$14K ﹤0.01%
90,200
ENERR
345
DELISTED
Accretion Acquisition Corp Right
ENERR
$14K ﹤0.01%
154,700
MCAFR
346
DELISTED
Mountain Crest Acquisition Corp. IV Rights
MCAFR
$13K ﹤0.01%
77,305
TRAQ.WS
347
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
$12K ﹤0.01%
108,439
HPX.WS
348
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$11K ﹤0.01%
45,850
MCAGR
349
DELISTED
Mountain Crest Acquisition Corp. V Right
MCAGR
$10K ﹤0.01%
54,100
PMGMW
350
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$10K ﹤0.01%
98,150

Similar funds

Gabelli & Co Investment Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Gabelli & Co Investment Advisers held 547 positions worth $771M, down 0.41% from $774M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Gabelli & Co Investment Advisers's Q3 2022 filing shows 54 new, 48 increased, 36 reduced and 76 closed positions. Its largest new stake was Avalara, Inc.: 155,200 shares worth $14.2M. The largest sale was Coherent Inc, an estimated $18.6M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

  • Gabelli & Co Investment Advisers's largest Q3 2022 buy was Avalara, Inc.: 155,200 shares worth $14.2M.
  • Gabelli & Co Investment Advisers added most to Alleghany Corp in Q3 2022, an estimated $26.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $4.24M.
  • Gabelli & Co Investment Advisers fully exited Coherent Inc in Q3 2022, selling an estimated $18.6M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 30% of its $771M portfolio in Q3 2022.
  • Gabelli & Co Investment Advisers opened 54 new positions and closed 76 in Q3 2022.
  • Gabelli & Co Investment Advisers's portfolio value fell 0.41% quarter-over-quarter to $771M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.